Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CERC

Cerecor (CERC) Stock Price, News & Analysis

Cerecor logo

About Cerecor Stock (NASDAQ:CERC)

Advanced Chart

Key Stats

Today's Range
$6.36
$6.75
50-Day Range
$2.06
$3.24
52-Week Range
$1.98
$4.50
Volume
112,663 shs
Average Volume
1.27 million shs
Market Capitalization
$642.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CERC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cerecor and its competitors with MarketBeat's FREE daily newsletter.

CERC Stock News Headlines

Aytu BioPharma Stock (NASDAQ:AYTU) Insider Trades
mTOR Inhibitors Global Market Report 2023
It’s my duty to share the “truth” I see behind this bible verse
Former CIA advisor Jim Rickards believes President Trump has just unlocked what the Bible foretold — a $150 trillion “birthright” tied to America’s untouched wealth. He says the Book of Genesis predicted this moment… and those who act now could be first in line to benefit. The full presentation is now live.
See More Headlines

CERC Stock Analysis - Frequently Asked Questions

Cerecor Inc. (NASDAQ:CERC) announced its quarterly earnings data on Sunday, August, 1st. The company reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $0.01. The business had revenue of $3.36 million for the quarter. Cerecor had a negative trailing twelve-month return on equity of 261.82% and a negative net margin of 1,194.82%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cerecor investors own include Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Aldeyra Therapeutics (ALDX), OPKO Health (OPK), VBI Vaccines (VBIV), Pfizer (PFE) and Agile Therapeutics (AGRX).

Company Calendar

Last Earnings
8/01/2021
Today
7/26/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CERC
CIK
1534120
Fax
N/A
Employees
31
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.57)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.50 million
Net Margins
-1,194.82%
Pretax Margin
N/A
Return on Equity
-261.82%
Return on Assets
-133.96%

Debt

Debt-to-Equity Ratio
0.79
Current Ratio
2.19
Quick Ratio
2.18

Sales & Book Value

Annual Sales
$6.70 million
Price / Sales
95.87
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.22 per share
Price / Book
30.41

Miscellaneous

Outstanding Shares
96,009,000
Free Float
N/A
Market Cap
$642.30 million
Optionable
Not Optionable
Beta
1.44

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:CERC) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners